Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
2019 · Journal of Experimental & Clinical Cancer Research · 105 citations
https://doi.org/10.1186/s13046-019-1420-8
G
Giuseppina Rea
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
539
Citations
13
h-index
13
i10-index
Giuseppina Rea is an academic researcher from Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale". The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Renal cell carcinoma treatment & Chemokine receptors and signaling. The author has an h-index of 13, co-authored 43 publications.
ORCID: 0000-0002-5420-395XPapers by this author
worksMutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
2018 · Journal of Experimental & Clinical Cancer Research · 20 citations
https://doi.org/10.1186/s13046-018-0952-7
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment
2023 · Hepatology International · 18 citations
https://doi.org/10.1007/s12072-023-10537-6
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients
2024 · British Journal of Cancer · 15 citations
https://doi.org/10.1038/s41416-024-02702-x
Additional file 2: of Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7422461
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat